Tapewire

Nasdaq · USD

IRMD

IRADIMED CORP

Export transactions ↓
Tapewire entity
4896
SEC CIK
0001325618
Parsed reports
427

Last 12 months

Inside the activity.

0 purchase rows · 116 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 2025020
Dec 2025015
Jan 2026012
Feb 202601
Mar 2026015
Apr 2026023
May 2026022
Jun 202606
Jul 202600
Aug 202600
Sep 202602
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
December 31, 2018 Filed Jan 3, 2019 23:07 UTC
JOHNSON BRENTExec. VP. Sales & Marketing
Tax withholdingCommon Stock 151 $24.46 $3,693.46
Disclosure

SEC source: 0000898432-19-000017 · form4.xml · nonDerivative · entry 2

JOHNSON BRENT · CIK 0001254747 · Exec. VP. Sales & Marketing

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,959

Read SEC document
December 31, 2018 Filed Jan 3, 2019 23:07 UTC
JOHNSON BRENTExec. VP. Sales & Marketing
Exercise / conversionCommon Stock 617 Not disclosed Not disclosed
Disclosure

SEC source: 0000898432-19-000017 · form4.xml · nonDerivative · entry 1

JOHNSON BRENT · CIK 0001254747 · Exec. VP. Sales & Marketing

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,110

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

Read SEC document
December 31, 2018 Filed Jan 3, 2019 23:04 UTC
Scott Christopher K.CFO & Secretary
Exercise / conversionRestricted Stock Units · Derivative 2,715 $0.00 $0.00
Disclosure

SEC source: 0000898432-19-000015 · form4.xml · derivative · entry 3

Scott Christopher K. · CIK 0001613803 · CFO & Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,716

Underlying: Common Stock · 2,715 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F2 · derivative.exercise_date: On January 4, 2016, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on January 4, 2017. The scheduled January 4, 2019 vesting was accelerated by the registrant, and the restricted stock units became vested as of December 31, 2018. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.

F2 · derivative.expiration_date: On January 4, 2016, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on January 4, 2017. The scheduled January 4, 2019 vesting was accelerated by the registrant, and the restricted stock units became vested as of December 31, 2018. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.

Read SEC document
December 31, 2018 Filed Jan 3, 2019 23:04 UTC
Scott Christopher K.CFO & Secretary
Tax withholdingCommon Stock 662 $24.46 $16,192.52
Disclosure

SEC source: 0000898432-19-000015 · form4.xml · nonDerivative · entry 2

Scott Christopher K. · CIK 0001613803 · CFO & Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,971

Read SEC document
December 31, 2018 Filed Jan 3, 2019 23:04 UTC
Scott Christopher K.CFO & Secretary
Exercise / conversionCommon Stock 2,715 Not disclosed Not disclosed
Disclosure

SEC source: 0000898432-19-000015 · form4.xml · nonDerivative · entry 1

Scott Christopher K. · CIK 0001613803 · CFO & Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,633

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

Read SEC document
December 14, 2018 Filed Dec 18, 2018 17:18 UTC
Casey Francis X.VP of Reg and Qual Assur
Exercise / conversionRestricted Stock Units · Derivative 425 $0.00 $0.00
Disclosure

SEC source: 0000898432-18-001510 · form4.xml · derivative · entry 3

Casey Francis X. · CIK 0001613661 · VP of Reg and Qual Assur

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 850

Underlying: Common Stock · 425 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F2 · derivative.exercise_date: On December 14, 2016, The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 14, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.

F2 · derivative.expiration_date: On December 14, 2016, The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 14, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.

Read SEC document
December 14, 2018 Filed Dec 18, 2018 17:18 UTC
Casey Francis X.VP of Reg and Qual Assur
Tax withholdingCommon Stock 104 $27.02 $2,810.08
Disclosure

SEC source: 0000898432-18-001510 · form4.xml · nonDerivative · entry 2

Casey Francis X. · CIK 0001613661 · VP of Reg and Qual Assur

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 51,712

Read SEC document
December 14, 2018 Filed Dec 18, 2018 17:18 UTC
Casey Francis X.VP of Reg and Qual Assur
Exercise / conversionCommon Stock 425 Not disclosed Not disclosed
Disclosure

SEC source: 0000898432-18-001510 · form4.xml · nonDerivative · entry 1

Casey Francis X. · CIK 0001613661 · VP of Reg and Qual Assur

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 51,816

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

Read SEC document
December 14, 2018 Filed Dec 18, 2018 17:32 UTC Exercise / conversionRestricted Stock Units · Derivative 750 $0.00 $0.00
Disclosure

SEC source: 0000898432-18-001516 · form4.xml · derivative · entry 4

Waldman Louis S. · CIK 0001613666 · Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,500

Underlying: Common Stock · 750 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F2 · derivative.exercise_date: On December 14, 2016, The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 14, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.

F2 · derivative.expiration_date: On December 14, 2016, The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 14, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.

Read SEC document
December 14, 2018 Filed Dec 18, 2018 17:32 UTC Tax withholdingCommon Stock 183 $27.02 $4,944.66
Disclosure

SEC source: 0000898432-18-001516 · form4.xml · nonDerivative · entry 2

Waldman Louis S. · CIK 0001613666 · Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,125

F2 · price: On December 14, 2016, The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 14, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.

Read SEC document
December 14, 2018 Filed Dec 18, 2018 17:32 UTC Exercise / conversionCommon Stock 750 Not disclosed Not disclosed
Disclosure

SEC source: 0000898432-18-001516 · form4.xml · nonDerivative · entry 1

Waldman Louis S. · CIK 0001613666 · Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,308

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

Read SEC document
December 14, 2018 Filed Dec 18, 2018 17:37 UTC
Nardi Steven M.VP MANUFACTURING
Exercise / conversionRestricted Stock Units · Derivative 750 $0.00 $0.00
Disclosure

SEC source: 0000898432-18-001518 · form4.xml · derivative · entry 3

Nardi Steven M. · CIK 0001613663 · VP MANUFACTURING

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,500

Underlying: Common Stock · 750 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F2 · derivative.exercise_date: On December 14, 2016, The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 14, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.

F2 · derivative.expiration_date: On December 14, 2016, The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 14, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.

Read SEC document
December 14, 2018 Filed Dec 18, 2018 17:37 UTC
Nardi Steven M.VP MANUFACTURING
Tax withholdingCommon Stock 183 $27.02 $4,944.66
Disclosure

SEC source: 0000898432-18-001518 · form4.xml · nonDerivative · entry 2

Nardi Steven M. · CIK 0001613663 · VP MANUFACTURING

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,125

Read SEC document
December 14, 2018 Filed Dec 18, 2018 17:37 UTC
Nardi Steven M.VP MANUFACTURING
Exercise / conversionCommon Stock 750 Not disclosed Not disclosed
Disclosure

SEC source: 0000898432-18-001518 · form4.xml · nonDerivative · entry 1

Nardi Steven M. · CIK 0001613663 · VP MANUFACTURING

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,308

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

Read SEC document
December 14, 2018 Filed Dec 18, 2018 17:23 UTC Exercise / conversionRestricted Stock Units · Derivative 4,348 $0.00 $0.00
Disclosure

SEC source: 0000898432-18-001513 · form4.xml · derivative · entry 2

Kennedy Jonathan · CIK 0001451629 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,348 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F2 · derivative.exercise_date: On December 14, 2016, The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 14, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.

F2 · derivative.expiration_date: On December 14, 2016, The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 14, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.

Read SEC document
December 14, 2018 Filed Dec 18, 2018 17:23 UTC Exercise / conversionCommon Stock 4,348 Not disclosed Not disclosed
Disclosure

SEC source: 0000898432-18-001513 · form4.xml · nonDerivative · entry 1

Kennedy Jonathan · CIK 0001451629 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,301

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

Read SEC document
December 14, 2018 Filed Dec 18, 2018 22:39 UTC Exercise / conversionRestricted Stock Units · Derivative 4,348 $0.00 $0.00
Disclosure

SEC source: 0000898432-18-001519 · form4.xml · derivative · entry 2

VUOTO ANTHONY · CIK 0001222060 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,348 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F2 · derivative.exercise_date: On December 14, 2016, The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 14, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.

F2 · derivative.expiration_date: On December 14, 2016, The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 14, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.

Read SEC document
December 14, 2018 Filed Dec 18, 2018 22:39 UTC Exercise / conversionCommon Stock 4,348 Not disclosed Not disclosed
Disclosure

SEC source: 0000898432-18-001519 · form4.xml · nonDerivative · entry 1

VUOTO ANTHONY · CIK 0001222060 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,673

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

Read SEC document
December 14, 2018 Filed Dec 18, 2018 22:35 UTC
Scott Christopher K.Chief Financial Officer & Secr
Exercise / conversionRestricted Stock Units · Derivative 3,417 $0.00 $0.00
Disclosure

SEC source: 0000898432-18-001517 · form4.xml · derivative · entry 3

Scott Christopher K. · CIK 0001613803 · Chief Financial Officer & Secr

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,834

Underlying: Common Stock · 3,417 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F2 · derivative.exercise_date: On December 14, 2016, The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 14, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.

F2 · derivative.expiration_date: On December 14, 2016, The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 14, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.

Read SEC document
December 14, 2018 Filed Dec 18, 2018 22:35 UTC
Scott Christopher K.Chief Financial Officer & Secr
Tax withholdingCommon Stock 833 $27.02 $22,507.66
Disclosure

SEC source: 0000898432-18-001517 · form4.xml · nonDerivative · entry 2

Scott Christopher K. · CIK 0001613803 · Chief Financial Officer & Secr

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,918

Read SEC document
December 14, 2018 Filed Dec 18, 2018 22:35 UTC
Scott Christopher K.Chief Financial Officer & Secr
Exercise / conversionCommon Stock 3,417 Not disclosed Not disclosed
Disclosure

SEC source: 0000898432-18-001517 · form4.xml · nonDerivative · entry 1

Scott Christopher K. · CIK 0001613803 · Chief Financial Officer & Secr

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,751

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

Read SEC document
December 14, 2018 Filed Dec 18, 2018 22:20 UTC
JOHNSON BRENTEXEX. VP, SALES & MARKETING
Exercise / conversionRestricted Stock Units · Derivative 750 $0.00 $0.00
Disclosure

SEC source: 0000898432-18-001511 · form4.xml · derivative · entry 3

JOHNSON BRENT · CIK 0001254747 · EXEX. VP, SALES & MARKETING

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,500

Underlying: Common Stock · 750 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F2 · derivative.exercise_date: On December 14, 2016, The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 14, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.

F2 · derivative.expiration_date: On December 14, 2016, The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 14, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.

Read SEC document
December 14, 2018 Filed Dec 18, 2018 22:20 UTC
JOHNSON BRENTEXEX. VP, SALES & MARKETING
Tax withholdingCommon Stock 183 $27.02 $4,944.66
Disclosure

SEC source: 0000898432-18-001511 · form4.xml · nonDerivative · entry 2

JOHNSON BRENT · CIK 0001254747 · EXEX. VP, SALES & MARKETING

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,493

Read SEC document
December 14, 2018 Filed Dec 18, 2018 22:20 UTC
JOHNSON BRENTEXEX. VP, SALES & MARKETING
Exercise / conversionCommon Stock 750 Not disclosed Not disclosed
Disclosure

SEC source: 0000898432-18-001511 · form4.xml · nonDerivative · entry 1

JOHNSON BRENT · CIK 0001254747 · EXEX. VP, SALES & MARKETING

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,676

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

Read SEC document
December 14, 2018 Filed Dec 18, 2018 22:17 UTC Exercise / conversionRestricted Stock Units · Derivative 4,348 $0.00 $0.00
Disclosure

SEC source: 0000898432-18-001509 · form4.xml · derivative · entry 2

ALLEN MONTY K · CIK 0001253352 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,348 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F2 · derivative.exercise_date: On December 14, 2016, The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 14, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.

F2 · derivative.expiration_date: On December 14, 2016, The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 14, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.

Read SEC document
December 14, 2018 Filed Dec 18, 2018 22:17 UTC Exercise / conversionCommon Stock 4,348 Not disclosed Not disclosed
Disclosure

SEC source: 0000898432-18-001509 · form4.xml · nonDerivative · entry 1

ALLEN MONTY K · CIK 0001253352 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,663

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

Read SEC document
December 07, 2018 Filed Dec 11, 2018 19:35 UTC
McCreery John KChief Operating Officer
GrantRestricted Stock Units · Derivative 4,330 $0.00 $0.00
Disclosure

SEC source: 0000898432-18-001458 · form4.xml · derivative · entry 1

McCreery John K · CIK 0001703458 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,330

Underlying: Common Stock · 4,330 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Iradimed Corporation's common stock.

F2 · derivative.exercise_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 7, 2019. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.

F2 · derivative.expiration_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 7, 2019. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.

Read SEC document
December 07, 2018 Filed Dec 11, 2018 19:25 UTC GrantRestricted Stock Units · Derivative 1,574 $0.00 $0.00
Disclosure

SEC source: 0000898432-18-001454 · form4.xml · derivative · entry 1

Waldman Louis S. · CIK 0001613666 · Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,574

Underlying: Common Stock · 1,574 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Iradimed Corporation's common stock.

F2 · derivative.exercise_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 7, 2019. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.

F2 · derivative.expiration_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 7, 2019. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.

Read SEC document
December 07, 2018 Filed Dec 11, 2018 19:41 UTC
Casey Francis X.VP of Reg and Qual Assur
GrantRestricted Stock Units · Derivative 1,574 $0.00 $0.00
Disclosure

SEC source: 0000898432-18-001461 · form4.xml · derivative · entry 1

Casey Francis X. · CIK 0001613661 · VP of Reg and Qual Assur

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,574

Underlying: Common Stock · 1,574 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Iradimed Corporation's common stock.

F2 · derivative.exercise_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 7, 2019. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.

F2 · derivative.expiration_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 7, 2019. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.

Read SEC document
December 07, 2018 Filed Dec 11, 2018 19:33 UTC
Nardi Steven M.VP MANUFACTURING
GrantRestricted Stock Units · Derivative 1,574 $0.00 $0.00
Disclosure

SEC source: 0000898432-18-001457 · form4.xml · derivative · entry 1

Nardi Steven M. · CIK 0001613663 · VP MANUFACTURING

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,574

Underlying: Common Stock · 1,574 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Iradimed Corporation's common stock.

F2 · derivative.exercise_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 7, 2019. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.

F2 · derivative.expiration_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 7, 2019. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.

Read SEC document
December 07, 2018 Filed Dec 11, 2018 19:37 UTC GrantRestricted Stock Units · Derivative 3,937 $0.00 $0.00
Disclosure

SEC source: 0000898432-18-001459 · form4.xml · derivative · entry 1

Kennedy Jonathan · CIK 0001451629 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,937

Underlying: Common Stock · 3,937 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Iradimed Corporation's common stock.

F2 · derivative.exercise_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 7, 2019. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.

F2 · derivative.expiration_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 7, 2019. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.

Read SEC document
December 07, 2018 Filed Dec 12, 2018 00:39 UTC
JOHNSON BRENTEXEX. VP, SALES & MARKETING
GrantRestricted Stock Units · Derivative 1,574 $0.00 $0.00
Disclosure

SEC source: 0000898432-18-001460 · form4.xml · derivative · entry 1

JOHNSON BRENT · CIK 0001254747 · EXEX. VP, SALES & MARKETING

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,574

Underlying: Common Stock · 1,574 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Iradimed Corporation's common stock.

F2 · derivative.exercise_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 7, 2019. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.

F2 · derivative.expiration_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 7, 2019. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.

Read SEC document
December 07, 2018 Filed Dec 12, 2018 00:26 UTC GrantRestricted Stock Units · Derivative 3,937 $0.00 $0.00
Disclosure

SEC source: 0000898432-18-001455 · form4.xml · derivative · entry 1

ALLEN MONTY K · CIK 0001253352 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,937

Underlying: Common Stock · 3,937 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Iradimed Corporation's common stock.

F2 · derivative.exercise_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 7, 2019. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.

F2 · derivative.expiration_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 7, 2019. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.

Read SEC document
December 07, 2018 Filed Dec 12, 2018 00:23 UTC GrantRestricted Stock Units · Derivative 3,937 $0.00 $0.00
Disclosure

SEC source: 0000898432-18-001453 · form4.xml · derivative · entry 1

VUOTO ANTHONY · CIK 0001222060 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,937

Underlying: Common Stock · 3,937 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Iradimed Corporation's common stock.

F2 · derivative.exercise_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 7, 2019. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.

F2 · derivative.expiration_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 7, 2019. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.

Read SEC document
December 07, 2018 Filed Dec 12, 2018 00:31 UTC
Scott Christopher K.CFO & Secretary
GrantRestricted Stock Units · Derivative 6,299 $0.00 $0.00
Disclosure

SEC source: 0000898432-18-001456 · form4.xml · derivative · entry 1

Scott Christopher K. · CIK 0001613803 · CFO & Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,299

Underlying: Common Stock · 6,299 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Iradimed Corporation's common stock.

F2 · derivative.exercise_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 7, 2019. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.

F2 · derivative.expiration_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 7, 2019. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.

Read SEC document
December 04, 2018 Filed Dec 6, 2018 18:04 UTC
McCreery John KChief Operating Officer
Exercise / conversionRestricted Stock Units · Derivative 738 $0.00 $0.00
Disclosure

SEC source: 0000898432-18-001415 · form4.xml · derivative · entry 3

McCreery John K · CIK 0001703458 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,214

Underlying: Common Stock · 738 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F2 · derivative.exercise_date: On December 4, 2017, The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 4, 2018. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.

F2 · derivative.expiration_date: On December 4, 2017, The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 4, 2018. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.

Read SEC document
December 04, 2018 Filed Dec 6, 2018 18:04 UTC
McCreery John KChief Operating Officer
Tax withholdingCommon Stock 180 $26.78 $4,820.40
Disclosure

SEC source: 0000898432-18-001415 · form4.xml · nonDerivative · entry 2

McCreery John K · CIK 0001703458 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,183

Read SEC document
December 04, 2018 Filed Dec 6, 2018 18:04 UTC
McCreery John KChief Operating Officer
Exercise / conversionCommon Stock 738 Not disclosed Not disclosed
Disclosure

SEC source: 0000898432-18-001415 · form4.xml · nonDerivative · entry 1

McCreery John K · CIK 0001703458 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,363

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

Read SEC document
December 04, 2018 Filed Dec 6, 2018 17:56 UTC
Casey Francis X.VP of Reg and Qual Assur
Exercise / conversionRestricted Stock Units · Derivative 738 $0.00 $0.00
Disclosure

SEC source: 0000898432-18-001412 · form4.xml · derivative · entry 3

Casey Francis X. · CIK 0001613661 · VP of Reg and Qual Assur

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,214

Underlying: Common Stock · 738 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F2 · derivative.exercise_date: On December 4, 2017, The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 4, 2018. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.

F2 · derivative.expiration_date: On December 4, 2017, The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 4, 2018. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.

Read SEC document
December 04, 2018 Filed Dec 6, 2018 17:56 UTC
Casey Francis X.VP of Reg and Qual Assur
Tax withholdingCommon Stock 178 $26.78 $4,766.84
Disclosure

SEC source: 0000898432-18-001412 · form4.xml · nonDerivative · entry 2

Casey Francis X. · CIK 0001613661 · VP of Reg and Qual Assur

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 51,391

Read SEC document
December 04, 2018 Filed Dec 6, 2018 17:56 UTC
Casey Francis X.VP of Reg and Qual Assur
Exercise / conversionCommon Stock 738 Not disclosed Not disclosed
Disclosure

SEC source: 0000898432-18-001412 · form4.xml · nonDerivative · entry 1

Casey Francis X. · CIK 0001613661 · VP of Reg and Qual Assur

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 51,569

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

Read SEC document
December 04, 2018 Filed Dec 6, 2018 18:18 UTC Exercise / conversionRestricted Stock Units · Derivative 738 $0.00 $0.00
Disclosure

SEC source: 0000898432-18-001419 · form4.xml · derivative · entry 4

Waldman Louis S. · CIK 0001613666 · Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,214

Underlying: Common Stock · 738 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F2 · derivative.exercise_date: On December 4, 2017, The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 4, 2018. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.

F2 · derivative.expiration_date: On December 4, 2017, The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 4, 2018. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.

Read SEC document
December 04, 2018 Filed Dec 6, 2018 18:18 UTC Tax withholdingCommon Stock 180 $26.78 $4,820.40
Disclosure

SEC source: 0000898432-18-001419 · form4.xml · nonDerivative · entry 2

Waldman Louis S. · CIK 0001613666 · Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 558

Read SEC document
December 04, 2018 Filed Dec 6, 2018 18:18 UTC Exercise / conversionCommon Stock 738 Not disclosed Not disclosed
Disclosure

SEC source: 0000898432-18-001419 · form4.xml · nonDerivative · entry 1

Waldman Louis S. · CIK 0001613666 · Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 738

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

Read SEC document
December 04, 2018 Filed Dec 6, 2018 18:08 UTC
Nardi Steven M.VP MANUFACTURING
Exercise / conversionRestricted Stock Units · Derivative 738 $0.00 $0.00
Disclosure

SEC source: 0000898432-18-001416 · form4.xml · derivative · entry 3

Nardi Steven M. · CIK 0001613663 · VP MANUFACTURING

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,214

Underlying: Common Stock · 738 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F2 · derivative.exercise_date: On December 4, 2017, The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 4, 2018. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.

F2 · derivative.expiration_date: On December 4, 2017, The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 4, 2018. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.

Read SEC document
December 04, 2018 Filed Dec 6, 2018 18:08 UTC
Nardi Steven M.VP MANUFACTURING
Tax withholdingCommon Stock 180 $26.78 $4,820.40
Disclosure

SEC source: 0000898432-18-001416 · form4.xml · nonDerivative · entry 2

Nardi Steven M. · CIK 0001613663 · VP MANUFACTURING

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 558

Read SEC document
December 04, 2018 Filed Dec 6, 2018 18:08 UTC
Nardi Steven M.VP MANUFACTURING
Exercise / conversionCommon Stock 738 Not disclosed Not disclosed
Disclosure

SEC source: 0000898432-18-001416 · form4.xml · nonDerivative · entry 1

Nardi Steven M. · CIK 0001613663 · VP MANUFACTURING

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 738

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

Read SEC document
December 04, 2018 Filed Dec 6, 2018 18:01 UTC Exercise / conversionRestricted Stock Units · Derivative 3,690 $0.00 $0.00
Disclosure

SEC source: 0000898432-18-001414 · form4.xml · derivative · entry 2

Kennedy Jonathan · CIK 0001451629 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,690

Underlying: Common Stock · 3,690 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F2 · derivative.exercise_date: On December 4, 2017, The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 4, 2018. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.

F2 · derivative.expiration_date: On December 4, 2017, The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 4, 2018. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.

Read SEC document
December 04, 2018 Filed Dec 6, 2018 18:01 UTC Exercise / conversionCommon Stock 3,690 Not disclosed Not disclosed
Disclosure

SEC source: 0000898432-18-001414 · form4.xml · nonDerivative · entry 1

Kennedy Jonathan · CIK 0001451629 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,953

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

Read SEC document
December 04, 2018 Filed Dec 6, 2018 23:14 UTC Exercise / conversionRestricted Stock Units · Derivative 3,690 $0.00 $0.00
Disclosure

SEC source: 0000898432-18-001418 · form4.xml · derivative · entry 2

VUOTO ANTHONY · CIK 0001222060 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,690

Underlying: Common Stock · 3,690 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F2 · derivative.exercise_date: On December 4, 2017, The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 4, 2018. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.

F2 · derivative.expiration_date: On December 4, 2017, The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 4, 2018. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.